课题基金 / 基金详情

MECHANISMS OF HYPERTRIGLYCERIDEMIA IN HUMANS

MECHANISMS OF HYPERTRIGLYCERIDEMIA IN HUMANS
人类高甘油三酯血症的机制
批准号:
7603418
负责人:
Gail Pairitz Jarvik
金额:
$0.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-04-01 至 2007-09-16

项目摘要

项目成果

Gail Pairitz Jarvik的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Cholesterol and triglyceride are two fats of interest in blood because they are associated with early coronary artery disease. Triglyceride in blood is carried in very low density lipoproteins (VLDL). The purpose of this study is to determine: 1) the mechanisms of primary hypertriglyceridemia related to VLDL overproduction and/or defective VLDL catabolism related to lipoprotein lipase or hepatic lipase; 2) the interaction of the above with secondary forms of hypertriglyceridemia; and 3) the response of LDL size, composition and mass to changes that occur in VLDL. The study of these subjects will help to understand the pathophysiological mechanisms of each group of disorders of cholesterol and triglyceride metabolism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Electronic Medical Records and Genomics (eMERGE) Network, Phase III
The Electronic Medical Records and Genomics (eMERGE) Network, Phase III
The Electronic Medical Records and Genomics (eMERGE) Network, Phase III
The Electronic Medical Records and Genomics (eMERGE) Network, Phase III
海外基金